{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:14:24Z","timestamp":1774865664379,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["82060152"],"award-info":[{"award-number":["82060152"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40256-022-00548-3","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T01:04:03Z","timestamp":1661994243000},"page":"647-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and Safety of Thyroid Hormone Therapy in Patients with Dilated Cardiomyopathy: A Systematic Review and Meta-analysis of RCTs"],"prefix":"10.1007","volume":"22","author":[{"given":"Xiaoai","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-8523","authenticated-orcid":false,"given":"Limin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"16","key":"548_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.3390\/jcm10163618","volume":"10","author":"K Zawadzka","year":"2021","unstructured":"Zawadzka K, Dziedzic R, Surdacki A, Chyrchel B. Thyroid hormones: an underestimated player in dilated cardiomyopathy? J Clin Med. 2021;10(16):3618. https:\/\/doi.org\/10.3390\/jcm10163618.","journal-title":"J Clin Med"},{"issue":"1","key":"548_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"H-P Schultheiss","year":"2019","unstructured":"Schultheiss H-P, Fairweather D, Caforio AL, Escher F, Hershberger RE, Lipshultz SE, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5(1):1\u201319. https:\/\/doi.org\/10.1038\/s41572-019-0084-1.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"548_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531\u201347. https:\/\/doi.org\/10.1038\/nrcardio.2013.105.","journal-title":"Nat Rev Cardiol"},{"key":"548_CR4","unstructured":"Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. [Updated 2021 Aug 11]. In: StatPearls\u00a0[Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441911\/"},{"issue":"9","key":"548_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/oxfordjournals.eurheartj.a059803","volume":"11","author":"M Komajda","year":"1990","unstructured":"Komajda M, Jais J, Reeves F, Goldfarb B, Bouhour J, Juillieres Y, et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 1990;11(9):824\u201331. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a059803.","journal-title":"Eur Heart J"},{"key":"548_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"JJ Atherton","year":"2016","unstructured":"UK NA-A, Atherton JJ, Bauersachs J, UK AJC, Carerj S, Ceconi C, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","journal-title":"Eur Heart J"},{"issue":"1","key":"548_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1\u201311. https:\/\/doi.org\/10.1186\/s13643-021-01626-4.","journal-title":"Syst Rev"},{"key":"548_CR8","doi-asserted-by":"publisher","unstructured":"Echocardiography Group CSoUM, Echocardiography Committee BoCM, Chinese Medical Doctor Association. Clinical guidelines for echocardiography in the diagnosis of cardiomyopathy. Chin J Ultrasound Imaging. 2020;29(10):17. https:\/\/doi.org\/10.3389\/fmicb.2015.00927","DOI":"10.3389\/fmicb.2015.00927"},{"key":"548_CR9","doi-asserted-by":"publisher","unstructured":"Cardiology CSo, Disease EBoCJoC, Cardiomyopathy CwgodaTo. Diagnosis and Treatment of Cardiomyopathy. Chin J Cardiovasc Dis. 2007;1:5\u201316. https:\/\/doi.org\/10.1016\/S1473-3099(13)70318-9.","DOI":"10.1016\/S1473-3099(13)70318-9"},{"issue":"06","key":"548_CR10","first-page":"1309","volume":"10","author":"W Dichun","year":"2010","unstructured":"Dichun W. Effect of low dose levothyroxine on heart failure in dilated cardiomyopathy. Chin J Misdiagn. 2010;10(06):1309\u201310.","journal-title":"Chin J Misdiagn"},{"key":"548_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3969\/j.issn.1673-016X.2008.03.008","volume":"3","author":"L Feng","year":"2008","unstructured":"Feng L, Yong W, Yumin Z. Effects of levothyroxine on cardiac function and cytokines in patients with dilated cardiomyopathy with severe heart failure. J Hunan Normal Univ. 2008;3:23\u20135. https:\/\/doi.org\/10.3969\/j.issn.1673-016X.2008.03.008.","journal-title":"J Hunan Normal Univ"},{"key":"548_CR12","first-page":"165","volume":"03","author":"Z Guisheng","year":"1997","unstructured":"Guisheng Z, Deshan J, Chunhua W, Xiuli L, Weixia G, Liran W, et al. Metoprolol combined with low dose thyroid hormone in the treatment of heart failure in dilated cardiomyopathy. Beijing Military Area Med. 1997;03:165\u20137.","journal-title":"Beijing Military Area Med"},{"issue":"07","key":"548_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.16252\/j.cnki.issn1004-0501-2011.07.015","volume":"32","author":"G Hongmei","year":"2011","unstructured":"Hongmei G, Dalong X, Julong T, Jianjun L, Juan Z, Changming Q, et al. Effect of low dose levothyroxine on dilated cardiomyopathy with normal thyroid syndrome. Sichuan Med. 2011;32(07):1078\u201380. https:\/\/doi.org\/10.16252\/j.cnki.issn1004-0501-2011.07.015.","journal-title":"Sichuan Med"},{"key":"548_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3969\/j.issn.1001-1439.2000.03.002","volume":"03","author":"F Lu","year":"2000","unstructured":"Lu F, Jinxia W, Jingxia S, Nan W. A preliminary study of thyroid hormone therapy for heart failure in dilated cardiomyopathy. J Clin Cardiovas Dis. 2000;03:100\u20132. https:\/\/doi.org\/10.3969\/j.issn.1001-1439.2000.03.002.","journal-title":"J Clin Cardiovas Dis"},{"issue":"02","key":"548_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3969\/j.issn.1671-0800.2009.02.024","volume":"21","author":"C Xufeng","year":"2009","unstructured":"Xufeng C, Xuebin L. Application of thyroxine in heart failure in dilated cardiomyopathy. Modern Pract Med. 2009;21(02):134\u20135. https:\/\/doi.org\/10.3969\/j.issn.1671-0800.2009.02.024.","journal-title":"Modern Pract Med"},{"issue":"10","key":"548_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.echo.2020.05.009","volume":"33","author":"HM Badran","year":"2020","unstructured":"Badran HM, Faheem N, Zidan A, Yacoub MH, Soltan G. Effect of short-term l-thyroxine therapy on left ventricular mechanics in idiopathic dilated cardiomyopathy. J Am Soc Echocardiogr. 2020;33(10):1234\u201344. https:\/\/doi.org\/10.1016\/j.echo.2020.05.009.","journal-title":"J Am Soc Echocardiogr"},{"issue":"13","key":"548_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.15887\/j.cnki.13-1389\/r.2015.13.023","volume":"8","author":"Z Zhiying","year":"2015","unstructured":"Zhiying Z, Zhanqing M, Tugang C, Weiling T, Weiguo S, Yuxin Z, et al. Clinical effect of long-term treatment of dilated cardiomyopathy heart failure with low T3 syndrome with levothyroxine. J Clin Rational Drug Use. 2015;8(13):32\u20133. https:\/\/doi.org\/10.15887\/j.cnki.13-1389\/r.2015.13.023.","journal-title":"J Clin Rational Drug Use"},{"issue":"5","key":"548_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0002-9343(96)00281-1","volume":"101","author":"P Moruzzi","year":"1996","unstructured":"Moruzzi P, Doria E, Agostoni PG. Medium-term effectiveness of l-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med. 1996;101(5):461\u20137. https:\/\/doi.org\/10.1016\/S0002-9343(96)00281-1.","journal-title":"Am J Med"},{"issue":"5","key":"548_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/0002-9149(94)90011-6","volume":"73","author":"P Moruzzi","year":"1994","unstructured":"Moruzzi P, Doria E, Agostoni PG, Capacchione V, Sganzerla P. Usefulness of l-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;73(5):374\u20138. https:\/\/doi.org\/10.1016\/0002-9149(94)90011-6.","journal-title":"Am J Cardiol"},{"issue":"7","key":"548_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3969\/j.issn.1006-2238.2014.07.018","volume":"49","author":"H Luhua","year":"2014","unstructured":"Luhua H. Effect of low dose thyroxine on heart failure in dilated cardiomyopathy. Jiangxi Med. 2014;49(7):602. https:\/\/doi.org\/10.3969\/j.issn.1006-2238.2014.07.018.","journal-title":"Jiangxi Med"},{"issue":"11","key":"548_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3760\/cma.j.issn.1008-6315.2003.11.015","volume":"19","author":"W Lizhi","year":"2003","unstructured":"Lizhi W, Xiangquan K, Yingli W, Xiaohua W, Yun Z, Qinghua Z, et al. Clinical study on long-term treatment of congestive heart failure with low-dose thyroxine. Clin Med China. 2003;19(11):987\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.1008-6315.2003.11.015.","journal-title":"Clin Med China"},{"issue":"4","key":"548_CR22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1152\/japplphysiol.00515.2005","volume":"99","author":"JA Kuzman","year":"2005","unstructured":"Kuzman JA, Thomas TA, Vogelsang KA, Said S, Anderson BE, Gerdes AM. Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters. J Appl Physiol. 2005;99(4):1428\u201333.","journal-title":"J Appl Physiol"},{"issue":"3\u20134","key":"548_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.vph.2009.10.001","volume":"52","author":"N Tribulova","year":"2010","unstructured":"Tribulova N, Knezl V, Shainberg A, Seki S, Soukup T. Thyroid hormones and cardiac arrhythmias. Vasc Pharmacol. 2010;52(3\u20134):102\u201312. https:\/\/doi.org\/10.1016\/j.vph.2009.10.001.","journal-title":"Vasc Pharmacol"},{"key":"548_CR24","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3969\/j.issn.0253-4304.2002.10.015","volume":"10","author":"M Shengyou","year":"2002","unstructured":"Shengyou M, Erzhou H, Qisheng Y, Yangchun L. Clinical effect of different doses of thyroid hormone on heart failure in dilated cardiomyopathy. Guangxi Med. 2002;10:1551\u20132. https:\/\/doi.org\/10.3969\/j.issn.0253-4304.2002.10.015.","journal-title":"Guangxi Med"},{"key":"548_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.04.016","author":"G Kozdag","year":"2005","unstructured":"Kozdag G, Ural D, Vural A, et al. Relation between free triiodothyronine\/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail. 2005. https:\/\/doi.org\/10.1016\/j.ejheart.2004.04.016.","journal-title":"Eur J Heart Fail"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-022-00548-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-022-00548-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-022-00548-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T01:04:35Z","timestamp":1667178275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-022-00548-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1007\/s40256-022-00548-3","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"11 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by grant  from  the National Natural Science Foundation of China (No.\u00a082060152), and Gansu Province\u00a0Science and Technique\u00a0Special Program,\u00a0Clinical Research Center for Metabolic Diseases, Gansu\u00a0(No.\u00a018JR2FA006).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Xiaoai Chen, Yun Bao, Chunxia Shi, and Limin Tian declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data generated or analyzed during this study are included in this published article (and its supplementary information files).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"XC had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: XC, LT. Acquisition, analysis, or interpretation of data: XC, CS. Drafting of the manuscript: XC. Critical revision of the manuscript for important intellectual content: XC, YB. Statistical analysis: XC. Obtained funding: LT. Administrative, technical, or material support: LT, YB. Supervision: LT, YB.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}